Skip to content

Assessment of the exposure-dependent perpetrator characteristics of metamizole on metabolic pathways and the pharmacokinetics of imatinib in healthy volunteers

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-513463-96-01
Acronym
K831
Enrollment
36
Registered
2024-09-02
Start date
2024-09-11
Completion date
Unknown
Last updated
2025-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pharmacokinetic trial in healthy volunteers

Interventions

None listed

Sponsors

Universitaetsklinikum Heidelberg AöR
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Germany

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026